| ZYMEWORKS DL-,00001 |
| USA |
| Gesundheit |
| US98985Y1082 / A3DSSN |
| ZA8 (Frankfurt) / ZYME (NASDAQ) |
| FRA:ZA8, ETR:ZA8, ZA8:GR, NASDAQ:ZYME |
| - |
| https://www.zymeworks.com.. |
|
Zymeworks Inc. is a biotechnology company focused on discovering, developing, and commercializing multifunctional biotherapeutics for cancer and other serious diseases. The company operates across therapeutic areas including oncology, inflammation, a..
>Volltext.. |
| 1812.51 Mio. EUR |
| 1810.67 Mio. EUR |
| 33.09 Mio. EUR |
| -130.55 Mio. EUR |
| -133.68 Mio. EUR |
| -1.79 EUR |
| 239.42 Mio. EUR |
| 159.9 Mio. EUR |
| -106.23 Mio. EUR |
| 5.73 |
| -69.78% |
| -103.59% |
| - |
| - |
| - |
| ZYMEWORKS |
| 23.10.26 |
|